PLAQUE, ATHEROSCLEROTIC
Clinical trials for PLAQUE, ATHEROSCLEROTIC explained in plain language.
Never miss a new study
Get alerted when new PLAQUE, ATHEROSCLEROTIC trials appear
Sign up with your email to follow new studies for PLAQUE, ATHEROSCLEROTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart attack survivors: can a Twice-Yearly shot melt artery plaque?
Disease control Recruiting nowThis study tests whether inclisiran, a twice-yearly injection, can reduce fatty plaque buildup in heart arteries of people who recently had a heart attack and have high cholesterol. About 334 adults aged 18-75 will receive inclisiran or standard care, and doctors will use special…
Matched conditions: PLAQUE, ATHEROSCLEROTIC
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Heart plaque showdown: combo therapy vs. High-Dose statin in new trial
Disease control Recruiting nowThis study tests whether a moderate-dose statin plus ezetimibe works as well as a high-dose statin alone to stabilize fatty plaques in heart arteries. About 408 adults with coronary artery disease will receive one of the two treatments for 52 weeks. Researchers will use special u…
Matched conditions: PLAQUE, ATHEROSCLEROTIC
Phase: PHASE4 • Sponsor: Korea University Anam Hospital • Aim: Disease control
Last updated May 07, 2026 18:42 UTC